(Q45903277)
Statements
PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab (English)
J D Jensen
A V Laenkholm
M B Jensen
E Santoni-Rugiu
M Andersson
15 December 2011